Farnesylthiosalicylic acid-loaded lipid-polyethylene glycol-polymer hybrid nanoparticles for treatment of glioblastoma


Creative Commons License

KAFFASHI A., Lule S., PEHLIVAN S. B., SARISOZEN C., VURAL İ., KOSUCU H., ...More

JOURNAL OF PHARMACY AND PHARMACOLOGY, vol.69, no.8, pp.1010-1021, 2017 (SCI-Expanded) identifier identifier identifier

Abstract

ObjectivesWe aimed to develop lipid-polyethylene glycol (PEG)-polymer hybrid nanoparticles, which have high affinity to tumour tissue with active ingredient, a new generation antineoplastic drug, farnesylthiosalicylic acid (FTA) for treatment of glioblastoma.